Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersen H. K., Spencer E. S. Cytomegalovirus infection among renal allograft recipients. Acta Med Scand. 1969 Jul-Aug;186(1-2):7–19. doi: 10.1111/j.0954-6820.1969.tb01432.x. [DOI] [PubMed] [Google Scholar]
- Anuras S., Piros J., Bonney W. W., Forker E. L., Colville D. S., Corry R. J. Liver disease in renal transplant recipients. Arch Intern Med. 1977 Jan;137(1):42–48. [PubMed] [Google Scholar]
- Berne T. V., Chatterjee S. N., Craig J. R., Payne J. E. Hepatic dysfunction in recipients of renal allografts. Surg Gynecol Obstet. 1975 Aug;141(2):171–175. [PubMed] [Google Scholar]
- Berne T. V., Fitzgibbons T. J., Silberman H. The effect of hepatitis B antigenemia on long-term success and hepatic disease in renal transplant recipients. Transplantation. 1977 Dec;24(6):412–415. doi: 10.1097/00007890-197712000-00002. [DOI] [PubMed] [Google Scholar]
- Craighead J. E., Hanshaw J. B., Carpenter C. B. Cytomegalovirus infection after renal allotransplantation. JAMA. 1967 Sep 4;201(10):725–728. [PubMed] [Google Scholar]
- Dickerman R. M., Niederhuber J. E., Eigenbrodt E., Fry W. J. Portal hypertension following renal transplantation. Surgery. 1978 Sep;84(3):322–328. [PubMed] [Google Scholar]
- Fiala M., Payne J. E., Berne T. V., Moore T. C., Henle W., Montgomerie J. Z., Chatterjee S. N., Guze L. B. Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis. 1975 Oct;132(4):421–433. doi: 10.1093/infdis/132.4.421. [DOI] [PubMed] [Google Scholar]
- Galbraith R. M., Eddleston A. L., Williams R., Zuckerman A. J. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet. 1975 Sep 20;2(7934):528–530. doi: 10.1016/s0140-6736(75)90897-1. [DOI] [PubMed] [Google Scholar]
- Luby J. P., Burnett W., Hull A. R., Ware A. J., Shorey J. W., Peters P. C. Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant. J Infect Dis. 1974 May;129(5):511–518. doi: 10.1093/infdis/129.5.511. [DOI] [PubMed] [Google Scholar]
- Murphy J. F., McDonald F. D., Dawson M., Reite A., Turcotte J., Fekety F. R., Jr Factors affecting the frequency infection in renal transplant recipients. Arch Intern Med. 1976 Jun;136(6):670–677. [PubMed] [Google Scholar]
- Nagington J. Cytomegalovirus antibody production in renal transplant patients. J Hyg (Lond) 1971 Dec;69(4):645–660. doi: 10.1017/s0022172400021926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagington J. Reactivation of hepatitis b after transplantation operations. Lancet. 1977 Mar 12;1(8011):558–560. doi: 10.1016/s0140-6736(77)91995-x. [DOI] [PubMed] [Google Scholar]
- Opelz G., Terasaki P. I. Graft survival rates and HLA antigen frequencies in renal cadaver transplant recipients with hepatitis B antigenemia. Transplantation. 1978 Mar;25(3):159–161. doi: 10.1097/00007890-197803000-00013. [DOI] [PubMed] [Google Scholar]
- Pirson Y., Alexandre G. P., Ypersele C. Long-term effect of hbs antigenemia on patient survival after renal transplantation. N Engl J Med. 1977 Jan 27;296(4):194–196. doi: 10.1056/NEJM197701272960404. [DOI] [PubMed] [Google Scholar]
- Pár A., Barna K., Hollós I., Kovács M., Miszlai Z., Patakfalvi A., Javor T. Levamisole in viral hepatitis. Lancet. 1977 Mar 26;1(8013):702–702. doi: 10.1016/s0140-6736(77)92141-9. [DOI] [PubMed] [Google Scholar]
- Sopko J., Anuras S. Liver disease in renal transplant recipients. Am J Med. 1978 Jan;64(1):139–146. doi: 10.1016/0002-9343(78)90190-0. [DOI] [PubMed] [Google Scholar]
- Sparberg M., Simon N., del Greco F. Intrahepatic cholestasis due to azathioprine. Gastroenterology. 1969 Oct;57(4):439–441. [PubMed] [Google Scholar]
- Ware A. J., Luby J. P., Eigenbrodt E. H., Long D. L., Hull A. R. Spectrum of liver disease in renal transplant recipients. Gastroenterology. 1975 Apr;68(4 Pt 1):755–764. [PubMed] [Google Scholar]
